Abstract
The clinical symptoms of community-acquired pneumonia (CAP) and coronavirus disease 2019 (COVID-19)-associated pneumonia are similar. Effective predictive markers are needed to differentiate COVID-19 pneumonia from CAP in the current pandemic conditions. Copeptin, a 39-aminoacid glycopeptide, is a C-terminal part of the precursor pre-provasopressin (pre-proAVP). The activation of the AVP system stimulates copeptin secretion in equimolar amounts with AVP. This study aims to determine serum copeptin levels in patients with CAP and COVID-19 pneumonia and to analyze the power of copeptin in predicting COVID-19 pneumonia. The study consists of 98 patients with COVID-19 and 44 patients with CAP. The basic demographic and clinical data of all patients were recorded, and blood samples were collected. The receiver operating characteristic (ROC) curve was generated and the area under the ROC curve (AUC) was measured to evaluate the discriminative ability. Serum copeptin levels were significantly higher in COVID-19 patients compared to CAP patients (10.2 ± 4.4 ng/ml and 7.1 ± 3.1 ng/ml; p < .001). Serum copeptin levels were positively correlated with leukocyte, neutrophil, and platelet count (r = -.21, p = .012; r = -.21, p = .013; r = -.20, p = .018; respectively). The multivariable logistic regression analysis revealed that increased copeptin (odds ratio [OR] = 1.183, 95% confidence interval [CI], 1.033-1.354; p = .015) and CK-MB (OR = 1.052, 95% CI, 1.013-1.092; p = .008) levels and decreased leukocyte count (OR = 0.829, 95% CI, 0.730-0.940; p = .004) were independent predictors of COVID-19 pneumonia. A cut-off value of 6.83 ng/ml for copeptin predicted COVID-19 with a sensitivity of 78% and a specificity of 73% (AUC: 0.764% 95 Cl: 0.671-0.856, p < .001). Copeptin could be a promising and useful biomarker to be used to distinguish COVID-19 patients from CAP patients.
Keywords: SARS coronavirus; biochemical analysis; coronavirus; pathogenesis; research and analysis methods; respiratory tract; virus classification.
【저자키워드】 coronavirus, Pathogenesis, respiratory tract, SARS Coronavirus, virus classification, biochemical analysis, research and analysis methods, 【초록키워드】 COVID-19, coronavirus disease, Coronavirus disease 2019, COVID-19 pneumonia, pandemic, Biomarker, Pathogenesis, Clinical symptoms, Pneumonia, neutrophil, virus, serum, sensitivity, specificity, ROC, Research, Patient, Platelet, respiratory tract, SARS Coronavirus, virus classification, respiratory, characteristic, patients, community-acquired pneumonia, COVID-19 patients, Platelet count, biochemical analysis, marker, AVP, power, Analysis, Odds ratio, independent predictors, COVID-19 patient, ROC Curve, AUC, Predictive, receiver operating characteristic, leukocyte, glycopeptide, Activation, biochemical, CK-MB, 95% CI, 95% confidence interval, Blood samples, Clinical data, clinical symptom, multivariable logistic regression, secretion, blood sample, cut-off value, precursor, Multivariable logistic regression analysis, was measured, predicted, collected, evaluate, determine, significantly higher, conditions, stimulate, C-terminal, were recorded, equimolar, independent predictor, patients with COVID-19, positively correlated, 【제목키워드】 COVID-19,